Celyad Oncology SA American Depositary Shares
CYAD
CYAD was delisted on the 18th of May, 2023.
8 hedge funds and large institutions have $15M invested in Celyad Oncology SA American Depositary Shares in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.
32% more capital invested
Capital invested by funds: $11.4M → $15M (+$3.61M)
11% less funds holding
Funds holding: 9 → 8 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$9.38M |
| 2 |
Morgan Stanley
New York
|
+$18.2K |
| 3 |
II
Inspire Investing
Meridian,
Idaho
|
+$361 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$138K |
| 2 |
Jane Street
New York
|
-$117K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$18.7K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$11.2K |
| 5 |
Millennium Management
New York
|
-$8.88K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Victory Capital Management
San Antonio,
Texas
| $14.5M | +$9.38M | +986,277 | +99% |
|
|
2
Morgan Stanley
New York
| $296K | +$18.2K | +1,915 | +5% |
|
|
3
Millennium Management
New York
| $124K | -$8.88K | -934 | -5% |
|
|
4
Wells Fargo
San Francisco,
California
| $52K | -$138K | -14,561 | -68% |
|
|
5
UBS Group
Zurich,
Switzerland
| $8K | -$18.7K | -1,964 | -64% |
|
|
6
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $4K | -$11.2K | -1,176 | -70% |
|
7
Bank of Montreal
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
8
Jane Street
New York
| – | -$117K | -10,790 | Closed |
|
|
PA
9
PSI Advisors
Tampa,
Florida
| – | -$7K | -700 | Closed |
|
|
II
10
Inspire Investing
Meridian,
Idaho
| – | +$361 | +38 | New |
|
CYAD Hedge Fund Activity: Q1 2020 in Review
8 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Celyad Oncology SA American Depositary Shares (CYAD) for Q1 2020, worth a combined $15M — up 32% from $11.4M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CYAD and 1 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 2 added.
The largest buyer was Victory Capital Management, adding an estimated $9.38M. The largest seller was Wells Fargo, cutting an estimated $138K.
- 8 institutional investors held Celyad Oncology SA American Depositary Shares (CYAD) as of Q1 2020, down from 9 in Q4 2019.
- Funds reported $15M of Celyad Oncology SA American Depositary Shares stock for Q1 2020, up 32% quarter-over-quarter.
- 1 fund opened new Celyad Oncology SA American Depositary Shares positions in Q1 2020 and 2 closed out, a net change of -1 holder.
- The largest Celyad Oncology SA American Depositary Shares buyer in Q1 2020 was Victory Capital Management, an estimated $9.38M added.
- The largest Celyad Oncology SA American Depositary Shares seller in Q1 2020 was Wells Fargo, an estimated $138K sold.
Based on aggregated 13F filings for Q1 2020.